argenx vs Laboratorios Rovi (ARGX.BR vs ROVI)

argenx (ARGX.BR) vs Laboratorios Rovi (ROVI) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

argenx (ARGX.BR) and Laboratorios Rovi (ROVI) compete in healthcare and pharma. Here are argenx and Laboratorios Rovi side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy argenx or Laboratorios Rovi.

argenx vs Laboratorios Rovi: the figures

argenx and Laboratorios Rovi figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that argenx or Laboratorios Rovi figure is not available, and we never estimate it.

3 key differences between argenx and Laboratorios Rovi

1. Growth: argenx grew sales +52.1% year on year in its latest quarter, against +20.0% for Laboratorios Rovi.
2. Valuation: argenx trades at 32.8x its annual earnings and Laboratorios Rovi at 17.6x; the market pays more for each dollar of argenx profit, usually because it expects more growth.
3. Size: argenx is worth €51.3 billion on the stock market, about 15.7 times Laboratorios Rovi (€3.3 billion).

argenx or Laboratorios Rovi: which fits your profile

• If you want growth: argenx is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): Laboratorios Rovi pays the higher dividend relative to its price.
• If you prefer caution: argenx has less debt relative to its profit, which usually gives more room in a bad year.
• If price is what matters most to you: Laboratorios Rovi trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither argenx nor Laboratorios Rovi wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How argenx and Laboratorios Rovi make money

argenx (ARGX.BR)

argenx is a biotech that earns its money from Vyvgart, its antibody-based treatment for autoimmune diseases such as myasthenia gravis and CIDP, sold in IV and under-the-skin forms. Nearly all sales come from this product, mostly in the US, followed by Japan and Europe, and it reinvests in research for new uses. Full argenx analysis.

Laboratorios Rovi (ROVI)

Rovi has two businesses. Specialty pharmaceuticals, its biggest, sells heparins such as biosimilar enoxaparin and bemiparin, plus drugs like the schizophrenia treatment Okedi. Its contract manufacturing arm produces injectable drugs and vaccines for other drugmakers, including Moderna. Spain is its largest market. Full Laboratorios Rovi analysis.

Frequently asked questions: argenx vs Laboratorios Rovi

Is argenx or Laboratorios Rovi the better stock?

Choosing between argenx and Laboratorios Rovi depends on what you are looking for. argenx is growing faster right now, and Laboratorios Rovi trades on the lower P/E. Fintols does not tell you whether to buy argenx or Laboratorios Rovi: it shows you the differences so you can decide.

Which pays a higher dividend, argenx or Laboratorios Rovi?

As of November 4, 2026, Laboratorios Rovi yields 1.52% and argenx pays none. Also check how much of their profit argenx and Laboratorios Rovi pay out: if it is more than they earn, it cannot last.

Which is more expensive, argenx or Laboratorios Rovi?

On P/E, argenx (32.8x) is more expensive than Laboratorios Rovi (17.6x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both argenx and Laboratorios Rovi?

Yes. Many people spread their money across several companies, such as argenx and Laboratorios Rovi, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying argenx or Laboratorios Rovi.

More comparisons with argenx or Laboratorios Rovi

• argenx vs Bayer
• argenx vs Grifols
• argenx vs Sanofi
• Grifols vs Laboratorios Rovi

More companies like argenx and Laboratorios Rovi: healthcare and pharma stocks. Educational content about argenx and Laboratorios Rovi, not investment advice.